Oncolytics Biotech Inc T.ONC

Phase 3 clinical trial costs for small molecule oncology dru

[Noteable]

The phase 3 clinical trial budget example for small molecule drugs discussed in the attached linked article adds up to $12.9 million.

However, clinical trial costs are highly dependent on a long list of factors that can vary substantially, particularly when biologics are trialed in combination with other biological drugs.  However as a general rule of thumb for small molecule drugs , pivotal Phase 3 studies cost a median of $41,117 per patient

https://www.linkedin.com/pulse/how-much-does-oncology-clinical-trial-cost-patricio-ledesma/

[Noteable]

A 2019 Italian Phase 3 costing study to assess  the estimated “per patient” total cost per single Oncologic Italian Cancer Center participating in a multicenter clinical trial with new anticancer biological agents using the activity-based costing (ABC) methodology found that on  average, a trial with immunotherapy drugs accounts for 12.659 Euro per patient, namely 2.302 Euro